US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

223.00

-4.7500-2.09%

Post-market: 223.660.6600+0.30%19:57 EDT

Volume:804.93K

Turnover:174.45M

Market Cap:562.96M

PE:- -

High:224.85

Open:221.88

Low:208.28

Close:227.75

52wk High:341.93

52wk Low:102.35

Shares:2.52M

Float Shares:2.52M

Volume Ratio:1.53

T/O Rate:31.88%

Dividend:0.91

Dividend Rate:0.41%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sonic Healthcare's Funding Risk is Growing

Analysts Conflicted on These Healthcare Names: CSL (OtherCMXHF) and Newron Pharmaceuticals SpA (OtherNWPHF)

HealthCo Healthcare and Wellness REIT Resolves Healthscope Standoff, Resumes Distributions

MT Newswires Live

Optiscan Advances InVue Surgical Imaging Device with U.S. FDA 510(k) Filing

Fisher & Paykel Healthcare Sells South Auckland Land to Health New Zealand for Over NZ$45 Million

MT Newswires Live

Radiopharm Secures FDA Guidance as RAD101 Advances Toward Pivotal Brain Metastases Trial

AdAlta advances EW-001 towards FDA engagement and Australian manufacturing

HealthCo Healthcare & Wellness REIT Declares Quarterly Distribution for September 2026

HealthCo REIT Resolves Healthscope Hospital Leases and Restores Distributions

Fisher & Paykel Healthcare Sells Drury Land to Health NZ for Future Hospital

Vital Healthcare Sets 2026 AGM to Ratify Manager and Board Reappointments

Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX) and Integra Lifesciences (IART)

Wall Street Analysts Are Bullish on Top Healthcare Picks

The Oceania Healthcare Dispute Was About Profit, Not Growth

Simply Wall St.

Aveanna Healthcare director resignation prompts governance reshuffle

Healthcare Stocks Fall Slightly

Teknova and Pluristyx Announce FDA Drug Master File for the PluriFreeze™ Cryopreservation System

FDA ends outbreak investigation of Cyclospora infections linked to lettuce

Analysts Offer Insights on Healthcare Companies: Nexalin Technology, Inc. (NXL) and Gain Therapeutics (GANX)

Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Rocket Pharmaceuticals (RCKT)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/LABU/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":223,"timestamp":1791489600000,"preClose":227.75,"halted":0,"volume":804929,"hourTrading":{"tag":"盘后","latestPrice":223.66,"preClose":223,"latestTime":"19:57 EDT","volume":4124,"amount":918785.7173,"timestamp":1791503872443,"change":0.66,"changeRate":0.00296,"amplitude":0.008427},"delay":0,"changeRate":-0.020856201975850714,"floatShares":2524486,"shares":2524486,"eps":0,"marketStatus":"Not Yet Opened","change":-4.75,"latestTime":"10-08 16:00:00 EDT","open":221.88,"high":224.8479,"low":208.28,"amount":174447835.0605,"amplitude":0.072746,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791532800000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":227.75,"sharesOutstanding":3074486,"nav":227.52,"aum":597123938.28,"dividendRate":0.004085,"bidAskSpread":0.003146,"preHourTrading":{"tag":"盘前","latestPrice":220.18,"preClose":227.75,"latestTime":"09:29 EDT","volume":6169,"amount":1385605.45651,"timestamp":1791466199999,"change":-7.57,"changeRate":-0.033238,"amplitude":0.038727},"postHourTrading":{"tag":"盘后","latestPrice":223.66,"preClose":223,"latestTime":"19:57 EDT","volume":4124,"amount":918785.7173,"timestamp":1791503872443,"change":0.66,"changeRate":0.00296,"amplitude":0.008427},"volumeRatio":1.526101,"impliedVol":1.0277,"impliedVolPercentile":0.9004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2524486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.526101,"shares":2524486,"dividePrice":0.911,"high":224.8479,"amplitude":0.072746,"preClose":227.75,"low":208.28,"week52Low":102.3547,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":223,"eps":0,"divideRate":0.004085,"volume":804929,"delay":0,"ttmEps":0,"open":221.88,"prevYearClose":159.39,"prevWeekClose":248.72,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":249.65,"twentyDayClose":266,"sixtyDayClose":277.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673776104","title":"Sonic Healthcare's Funding Risk is Growing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673776104","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673776104?lang=en_us&edition=fundamental","pubTime":"2026-10-05 06:56","pubTimestamp":1791154560,"startTime":"0","endTime":"0","summary":"2256 GMT - Funding risk is growing for Sonic Healthcare, says UBS. \"While management has historically deemed U.S. and German funding reforms as unlikely, we believe growing policy momentum makes that view increasingly difficult to sustain,\" UBS says. In the U.S., PAMA reimbursement cuts have been proposed. These would reduce earnings by A$15 million, UBS says. In Germany, the local laboratory association has warned reforms could reduce private billing revenues by 34%. \"Notably, the debate has shifted from whether reform proceeds to how severe the impact will be,\" UBS says. \"We remain more optimistic than the industry's assumptions, modelling a 4% revenue headwind.\" Sonic ended last week at A$18.46. The stock is down 22% from its mid-August high.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4534","LU1863844665.USD","BK4585","LU1829250122.USD","LABU","BK7124","BK4588","LU3187612489.SGD","LU1863844749.USD","BK4118","SHL.AU","XBI","XLV","UBS","IE0034235071.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673776102","title":"Analysts Conflicted on These Healthcare Names: CSL (OtherCMXHF) and Newron Pharmaceuticals SpA (OtherNWPHF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673776102","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673776102?lang=en_us&edition=fundamental","pubTime":"2026-10-05 06:40","pubTimestamp":1791153611,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on CSL (CMXHF) and Newron Pharmaceuticals SpA (NWPHF). CSL (CMXHF) I...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-csl-othercmxhf-and-newron-pharmaceuticals-spa-othernwphf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-csl-othercmxhf-and-newron-pharmaceuticals-spa-othernwphf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CMXHF","XBI","XLV","BK4585","HCSG","BK4588","LABU","BK4581","NWPHF","LU0029874061.USD","BK4137","BK4007","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673776676","title":"HealthCo Healthcare and Wellness REIT Resolves Healthscope Standoff, Resumes Distributions","url":"https://stock-news.laohu8.com/highlight/detail?id=2673776676","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673776676?lang=en_us&edition=fundamental","pubTime":"2026-10-05 06:33","pubTimestamp":1791153224,"startTime":"0","endTime":"0","summary":"HealthCo Healthcare and Wellness REIT  reached binding agreements covering the remaining 10 Healthscope hospitals owned by the company and its Unlisted Healthcare Fund, clearing the way for distributions to be reinstated, according to a Monday filing with the Australian bourse.The new 20-year leases with Healthe Care, Acurio, and KnG Group are expected to preserve the portfolio's AU$1.35 billion valuation while reducing the largest tenant concentration to 31% from 57% and extending the weighted average lease expiry by 2.9 years to 13.5 years, per the filing.The leases will also provide consumer price index-linked or 3% annual rent escalations, with an around 12% incentive funded from existing liquidity, the filing said.The transition to the new operators is expected to be completed by Nov. 30, with Healthscope continuing to operate the hospitals until then.The company declared a fiscal first quarter distribution of AU$0.015 per unit, in line with its AU$0.06 fiscal 2027 guidance, with ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["8C8U.SI","RNTY","JJJ.SI","CFA.SI","LU0128526141.USD","RJMG","SRT.SI","BPRE","GLS.SI","BK4588","BK4137","BK7149","DFRA","IQRA","BK4585","XLV","PSCF","LABU","SRU.SI","YLDW","CLR.SI","XBI","BK7156","MDIV","BK4581","HCSG","BK6142","LU0029874061.USD","IVRA","HCW.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673776929","title":"Optiscan Advances InVue Surgical Imaging Device with U.S. FDA 510(k) Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673776929","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673776929?lang=en_us&edition=fundamental","pubTime":"2026-10-05 06:27","pubTimestamp":1791152862,"startTime":"0","endTime":"0","summary":"Optiscan Imaging Limited ( ($AU:OIL) ) has issued an update. Optiscan Imaging Limited has submitted a U.S. FDA 510(k) application for its InVue pre...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/optiscan-advances-invue-surgical-imaging-device-with-u-s-fda-510k-filing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/optiscan-advances-invue-surgical-imaging-device-with-u-s-fda-510k-filing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4588","OIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673765587","title":"Fisher & Paykel Healthcare Sells South Auckland Land to Health New Zealand for Over NZ$45 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2673765587","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673765587?lang=en_us&edition=fundamental","pubTime":"2026-10-05 06:16","pubTimestamp":1791152175,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare  agreed to sell 13 hectares of its Karaka Road site in Drury to Health New Zealand for NZ$45.3 million, paving the way for a future hospital to serve South Auckland, according to a Monday filing with the New Zealand and Australian bourses.The site will form part of the company's planned second New Zealand campus, with the remaining land retained for future development, per the filing.Settlement is expected to occur between March and June 2027, subject to certain conditions, while the rezoning application for the wider site remains under review by Auckland Council, the filing said.The transaction will be recognized as an exceptional item, with its financial impact excluded from the previously issued fiscal 2027 earnings guidance, the filing added.The company expects fiscal 2027 net profit after tax of around NZ$525 million to NZ$565 million and operating revenue of about NZ$2.47 billion to NZ$2.57 billion, an earlier filing showed.The company's New Zealand sha","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FNZ.NZ","NZ50G.NZ","BK7501","XLV","BK4585","BK7007","BK4588","FPH.NZ","BK8004","BK4581","LABU","NZT.NZ","T10G.NZ","XBI","NZ20C.NZ","FPH.AU","NZG.NZ","TNZ.NZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673765457","title":"Radiopharm Secures FDA Guidance as RAD101 Advances Toward Pivotal Brain Metastases Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2673765457","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673765457?lang=en_us&edition=fundamental","pubTime":"2026-10-05 06:12","pubTimestamp":1791151954,"startTime":"0","endTime":"0","summary":"An announcement from Radiopharm Theranostics Limited ( ($AU:RAD) ) is now available. Radiopharm Theranostics has completed a productive End-of-Phas...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/radiopharm-secures-fda-guidance-as-rad101-advances-toward-pivotal-brain-metastases-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/radiopharm-secures-fda-guidance-as-rad101-advances-toward-pivotal-brain-metastases-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673477651","title":"AdAlta advances EW-001 towards FDA engagement and Australian manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673477651","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673477651?lang=en_us&edition=fundamental","pubTime":"2026-10-05 06:02","pubTimestamp":1791151321,"startTime":"0","endTime":"0","summary":"The latest update is out from AdAlta Ltd. ( ($AU:1AD) ). AdAlta has secured Joint Development Committee approval with Shanghai Cell Therapy Group f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adalta-advances-ew-001-towards-fda-engagement-and-australian-manufacturing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adalta-advances-ew-001-towards-fda-engagement-and-australian-manufacturing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","EES","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673763537","title":"HealthCo Healthcare & Wellness REIT Declares Quarterly Distribution for September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673763537","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673763537?lang=en_us&edition=fundamental","pubTime":"2026-10-05 05:58","pubTimestamp":1791151098,"startTime":"0","endTime":"0","summary":"HealthCo Healthcare & Wellness REIT ( ($AU:HCW) ) has shared an announcement. HealthCo Healthcare & Wellness REIT has declared a quarterly distribu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/healthco-healthcare-wellness-reit-declares-quarterly-distribution-for-september-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/healthco-healthcare-wellness-reit-declares-quarterly-distribution-for-september-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVRA","MDIV","BK4137","BK4585","XBI","BPRE","PSCF","LU0029874061.USD","HCSG","BK4588","BK4581","LU0128526141.USD","RJMG","LABU","REIT","XLV","YLDW","RNTY","DFRA","IQRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673776355","title":"HealthCo REIT Resolves Healthscope Hospital Leases and Restores Distributions","url":"https://stock-news.laohu8.com/highlight/detail?id=2673776355","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673776355?lang=en_us&edition=fundamental","pubTime":"2026-10-05 05:58","pubTimestamp":1791151090,"startTime":"0","endTime":"0","summary":"An update from HealthCo Healthcare & Wellness REIT ( ($AU:HCW) ) is now available. HealthCo Healthcare & Wellness REIT has executed binding agreeme...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/healthco-reit-resolves-healthscope-hospital-leases-and-restores-distributions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/healthco-reit-resolves-healthscope-hospital-leases-and-restores-distributions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IQRA","RNTY","BK4585","BK4588","BPRE","MDIV","DFRA","REIT","IVRA","RJMG","XBI","XLV","PSCF","BK4581","LABU","YLDW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673775183","title":"Fisher & Paykel Healthcare Sells Drury Land to Health NZ for Future Hospital","url":"https://stock-news.laohu8.com/highlight/detail?id=2673775183","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673775183?lang=en_us&edition=fundamental","pubTime":"2026-10-05 03:47","pubTimestamp":1791143261,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare Corporation Limited ( ($NZ:FPH) ) has shared an announcement. Fisher & Paykel Healthcare has agreed to sell 13 hectares ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-sells-drury-land-to-health-nz-for-future-hospital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-sells-drury-land-to-health-nz-for-future-hospital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4581","BK4585","XBI","XLV","FPH.NZ","BK8004","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673185775","title":"Vital Healthcare Sets 2026 AGM to Ratify Manager and Board Reappointments","url":"https://stock-news.laohu8.com/highlight/detail?id=2673185775","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673185775?lang=en_us&edition=fundamental","pubTime":"2026-10-05 03:47","pubTimestamp":1791143250,"startTime":"0","endTime":"0","summary":"Vital Healthcare Property ( ($NZ:VHP) ) has provided an update. Vital Healthcare Property Trust has issued its 2026 Annual Meeting notice, virtual ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vital-healthcare-sets-2026-agm-to-ratify-manager-and-board-reappointments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vital-healthcare-sets-2026-agm-to-ratify-manager-and-board-reappointments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","XLV","HCSG","BK4137","BK8059","BK4585","BK4588","XBI","BK4581","LABU","LU0128526141.USD","BK8073","VHP.NZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672725428","title":"Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX) and Integra Lifesciences (IART)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672725428","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672725428?lang=en_us&edition=fundamental","pubTime":"2026-10-03 21:40","pubTimestamp":1791034821,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Perspective Therapeutics (CATX) and Integra Lifesciences (IART). ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-perspective-therapeutics-catx-and-integra-lifesciences-iart-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-perspective-therapeutics-catx-and-integra-lifesciences-iart-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","XLV","LU0029874061.USD","BK4139","IART","LU0128526141.USD","BK4588","HCSG","BK4581","CATX","BK4585","BK4137","BK4082","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672742406","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2672742406","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672742406?lang=en_us&edition=fundamental","pubTime":"2026-10-03 09:50","pubTimestamp":1790992231,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Insulet (PODD) and Viridian Therapeutics (VRDN) with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-369?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-369?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LU0728928796.USD","BK4082","LABU","BK4566","VRDN","XLV","XBI","PODD","BK4137","BK4585","BK4139","LU2324357040.USD","LU0029874061.USD","BK4551","BK4588","LU2065171402.SGD","LU1084165304.USD","LU2065171311.SGD","LU2065170008.USD","BK4581","LU2065169927.USD","LU0128526141.USD","LU1119994496.HKD","LU1261432733.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672747267","title":"The Oceania Healthcare Dispute Was About Profit, Not Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2672747267","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672747267?lang=en_us&edition=fundamental","pubTime":"2026-10-03 08:34","pubTimestamp":1790987677,"startTime":"0","endTime":"0","summary":"If you had backed Oceania Healthcare on 1 January and simply held through recent results, the outcome would sting. Holding Oceania Healthcare from the start of the year would have meant a 21.5% loss, including dividends. That decline now sits alongside a period where revenue reached NZ$135.769 million in H2 2026 while net income swung to a loss. If those were the final numbers, what did the original 13.8% revenue growth and 29.3% margin assumptions fail to allow for?\nNarratives are how...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6033000-choice1-card/1788938511465","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6033000-choice1-card/1788938511465"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/nz/healthcare/nzx-oca/oceania-healthcare-shares/news/the-oceania-healthcare-dispute-was-about-profit-not-growth","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/nz/healthcare/nzx-oca/oceania-healthcare-shares/news/the-oceania-healthcare-dispute-was-about-profit-not-growth","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4581","XLV","BK8050","BK4585","LABU","XBI","OCA.NZ","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672415587","title":"Aveanna Healthcare director resignation prompts governance reshuffle","url":"https://stock-news.laohu8.com/highlight/detail?id=2672415587","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672415587?lang=en_us&edition=fundamental","pubTime":"2026-10-03 05:18","pubTimestamp":1790975895,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Aveanna Healthcare Holdings ( ($AVAH) ). On October 1, 2026, Aveanna Healthcare Holdings Inc. announced that Cl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aveanna-healthcare-director-resignation-prompts-governance-reshuffle?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aveanna-healthcare-director-resignation-prompts-governance-reshuffle?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","XBI","BK4137","BK4585","BK4196","BK4581","BK4588","AVAH","HCSG","LU0029874061.USD","LU0128526141.USD","LABU","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749751","title":"Healthcare Stocks Fall Slightly","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749751","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749751?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:51","pubTimestamp":1790974260,"startTime":"0","endTime":"0","summary":"Health-care companies edged lower, as a risk-on mood weighed on the typically defensive sector.Novartis struck a deal valued at up to $7.8 billion to license a messenger RNA drug candidate from Abogen Biosciences and gain options over future therapies, turning to China to fill its pipeline.Many of the world's biggest drugmakers have set their sights on China to look for new drug ideas, seeking to bolster their portfolios in preparation for older medicines going off patent. Novartis has sealed several tie-ups with emerging Chinese biotech players in recent years.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4137","HCSG","BK4585","LU0128526141.USD","XBI","LABU","XLV","LU0029874061.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672674992","title":"Teknova and Pluristyx Announce FDA Drug Master File for the PluriFreeze™ Cryopreservation System","url":"https://stock-news.laohu8.com/highlight/detail?id=2672674992","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672674992?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:01","pubTimestamp":1790971260,"startTime":"0","endTime":"0","summary":"Developers of advanced therapies using PluriFreeze during preclinical stages can seamlessly scale to clinical manufacturing and cross-reference the Drug Master File in FDA submissionsHOLLISTER, Calif.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/02/3374011/0/en/teknova-and-pluristyx-announce-fda-drug-master-file-for-the-plurifreeze-cryopreservation-system.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443978.SGD","LU2746668461.USD","IE00BKVL7J92.USD","LU0170899867.USD","BK4006","LU0149725797.USD","LU0267386448.USD","LU0882574139.USD","CMC","IE00BZ1G4Q59.USD","LU1363072403.SGD","EES","LU2237443895.HKD","IE00B1BXHZ80.USD","DMF","LU2237443382.USD","LU2237443465.HKD","LU2237443622.USD","LU0971096721.USD","IE00BHPRN162.USD","LABU","LU0234572021.USD","BK4585","LU2746668974.SGD","LU2237443549.SGD","IND","IE00BFXG1179.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672874619","title":"FDA ends outbreak investigation of Cyclospora infections linked to lettuce","url":"https://stock-news.laohu8.com/highlight/detail?id=2672874619","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672874619?lang=en_us&edition=fundamental","pubTime":"2026-10-03 03:10","pubTimestamp":1790968223,"startTime":"0","endTime":"0","summary":"The FDA has concluded its outbreak investigation of Cyclospora infections linked to iceberg lettuce sourced from central Mexico and recalled by Tay...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-ends-outbreak-investigation-of-cyclospora-infections-linked-to-lettuce-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-ends-outbreak-investigation-of-cyclospora-infections-linked-to-lettuce-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672746829","title":"Analysts Offer Insights on Healthcare Companies: Nexalin Technology, Inc. (NXL) and Gain Therapeutics (GANX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672746829","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672746829?lang=en_us&edition=fundamental","pubTime":"2026-10-03 02:30","pubTimestamp":1790965805,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Nexalin Technology, Inc. (NXL) and Gain Therapeutics...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nexalin-technology-inc-nxl-and-gain-therapeutics-ganx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nexalin-technology-inc-nxl-and-gain-therapeutics-ganx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","HCSG","BK4588","BK4139","BK4082","GANX","BK4137","LABU","BK4581","LU0029874061.USD","LU0128526141.USD","XLV","XBI","NXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672254745","title":"Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Rocket Pharmaceuticals (RCKT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672254745","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672254745?lang=en_us&edition=fundamental","pubTime":"2026-10-03 02:00","pubTimestamp":1790964026,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Autolus Therapeutics (AUTL) and Rocket Pharmaceutica...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-autolus-therapeutics-autl-and-rocket-pharmaceuticals-rckt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-autolus-therapeutics-autl-and-rocket-pharmaceuticals-rckt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","XLV","HCSG","BK4581","XBI","LABU","AUTL","BK4137","BK4139","BK4588","RCKT","LU0029874061.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":22,"pageCount":10,"totalSize":427,"code":"91000000","status":"200"}]}}